Drug Topics

APRIL 26, 2024

As the H5N1 bird flu virus continues to spread across dairy cattle in the US, researchers and government health officials are ramping up testing to stop the spread.

201

201

STAT

APRIL 26, 2024

New federal rules aimed at limiting the spread of the H5N1 bird flu virus among dairy cattle go into effect Monday, but detailed guidance documents released Friday by the U.S. Department of Agriculture reveal its mandatory testing order is less stringent than initially described. While that is easing concerns from farmers and veterinarians about the economic and logistical burden of testing, it leaves questions about how effective the testing program will be at containing additional outbreaks.

Documentation 145

Documentation 145

Drug Topics

APRIL 26, 2024

The clinical manifestations of shingles can be divided into 3 phases.

187

187

STAT

APRIL 26, 2024

On a spring afternoon in Tucson, Ariz., about a half dozen children and teens hung out in the sunny common room of Pima County’s Crisis Response Center. Beyond the pastel-painted room stretched a long, wide hall where partitions separated individual beds, many left unmade with rumpled sheets. Wearing scrubs, the kids sat in rocking chairs, watched TV, talked and laughed.

145

145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

APRIL 26, 2024

On this month's episode Laura Gillespie, PharmD, discusses her paper “Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile Rates.

139

139

Fierce Pharma

APRIL 26, 2024

After a negative phase 3 readout, Gilead Sciences is taking a $2.4 billion impairment charge on Trodelvy, which serves as the cornerstone of the company’s solid tumor ambition. | After a negative phase 3 readout, Gilead Sciences is taking a $2.4 billion impairment charge on the antibody-drug conjugate Trodelvy. With a busy year ahead across therapeutic areas, CEO Dan O'Day emphasized a "time of focused execution.

133

133

STAT

APRIL 26, 2024

Hospitals and health care systems across the United States have long been expected to provide patients with high-quality, cutting-edge care and outcomes — while staying cost-effective. Their shared mission is to continue to improve the care they provide their patients; their shared responsibility is to do so without increasing costs by shifting from fee-for-service to value-based care.

Hospitals 131

Hospitals 131

Fierce Pharma

APRIL 26, 2024

Ten years after dipping its toes into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained FDA approval for the acquired treatment. | Ten years after dipping its toe into the gene therapy pool in a licensing deal with Spark Therapeutics, Pfizer has gained an FDA approval for the acquired treatment. The U.S. regulator has endorsed Beqvez for adults with the bleeding disorder hemophilia B.

FDA 130

FDA 130

STAT

APRIL 26, 2024

WASHINGTON — The Biden administration is walking away from a plan to permanently bar menthol cigarettes, for now. Regulators had already pushed back the ban several times amid concerns that it would unfairly target Black smokers and potentially alienate voters. Yet the regulation is heavily backed by public health groups and a number of federal health officials, who insist it is still in the works, just delayed — again.

FDA 128

FDA 128

pharmaphorum

APRIL 26, 2024

Explore the latest advancements and initiatives in kidney disease research, driving change for patients with kidney conditions. Learn more about the current research landscape and potential breakthroughs in treatment from Kidney Research UK.

126

126

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

APRIL 26, 2024

Inpatient volume growth across HCA Healthcare’s entire hospital portfolio and other steady gains on payer mix, length of stay and operating expenses have set the large chain on a strong trajectory | CEO Sam Hazen told investors that widespread inpatient volume increases fueled "the best portfolio experience I think I’ve seen in my experience in the company.

Hospitals 124

Hospitals 124

Pharmacy Times

APRIL 26, 2024

The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.

Labelling 123

Labelling FDA 123

Fierce Healthcare

APRIL 26, 2024

Elevance Health's pharmacy benefit manager CarelonRx is launching a new solution that aims to make it easier for employers to plan for the future around specialty pharmacy costs while connecting me | CarelonRx is launching a new solution that aims to make it easier for employers to plan for the future around specialty pharmacy costs, while connecting members with critical support to manage their conditions.

Specialty Pharmacies 124

Specialty Pharmacies 124

Drug Topics

APRIL 26, 2024

Fidanacogene elaparvovec-dzkt (Beqvez) is a 1 time treatment that allows patients with hemophilia B to produce factor IX themselves.

FDA 123

FDA 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

APRIL 26, 2024

AbbVie’s immunology heirs Skyrizi and Rinvoq are proving booming growth to make up for once-king Humira’s continuous sales slide. | As Humira continues its sales free fall, newer Skyrizi is proving a worthy successor with nearly matching sales ahead of an upcoming FDA decision in ulcerative colitis.

FDA 122

FDA 122

pharmaphorum

APRIL 26, 2024

Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic solutions to improve outcomes in the developing world.

116

116

BioPharm

APRIL 26, 2024

Beqvez (fidanacogene elaparvovec-dzkt), a one-time gene therapy, helps adults with hemophilia B produce factor IX themselves instead of receiving regular intravenous infusions.

FDA 116

FDA 116

Drug Topics

APRIL 26, 2024

Continuous glucose monitors (CGMs) empower patients with diabetes to take a more active role in managing their condition, but without proper training, many of these advantages become limited.

112

112

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

APRIL 26, 2024

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is likely to be low key. We plan to manicure the Pharmalot grounds, promenade with the official mascots, and catch up on our napping. We may also hold a listening party, where the rotation may include this , this , this and this.

Specialty Pharmacies 112

Specialty Pharmacies Hospitals 112

Drug Topics

APRIL 26, 2024

Kelly Malkamaki, RPh, senior product pharmacy analyst at AssureCare, shared her experience and thoughts on medication adherence in the pharmacy.

112

112

STAT

APRIL 26, 2024

WASHINGTON — A House committee next month plans to mark up legislation that would restrict U.S. biotechnology companies from doing business with a Chinese company that makes key drug ingredients, according to five lobbyists tracking the BIOSECURE Act. The goal is for the House to pass the bill before the July 4 recess, setting it up to be included in a year-end must-pass legislative package.

Packaging 112

Packaging 112

Drug Topics

APRIL 26, 2024

US health officials are growing increasingly worried about rising syphilis cases and have begun creating framework to slow down the spread.

112

112

STAT

APRIL 26, 2024

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims. The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an ins

Hospitals 112

Hospitals Insurance 112

BioPharm

APRIL 26, 2024

The collaboration aims to scale-up TreeFrog’s process to produce and amplify cells for Vertex’s type 1 diabetes cell therapies.

111

111

pharmaphorum

APRIL 26, 2024

In an ambitious move, Moderna has teamed up with OpenAI, the artificial intelligence company behind ChatGPT, to further integrate generative AI (GenAI) across its mRNA drug development and manufacturing operations.

111

111

European Pharmaceutical Review

APRIL 26, 2024

A paper has reported the first time that 3D printing has facilitated two active pharmaceutical ingredients (APIs) to be combined in the same formulation. This method enables the number of administrations of the drug evaluated to be minimised, the researchers found. The authors aimed to evaluate and compare the efficacy and acceptability of chewable 3D printed medicines containing citrulline, isoleucine, and valine alone or in combination.

Compounding 110

Compounding Hospitals 110

STAT

APRIL 26, 2024

It’s another busy day in my spine surgery clinic when my phone rings. Patients are waiting, but I’d be unwise to put off the caller: a physician calling from a health insurance company. This peer-to-peer call is part of the prior authorization process; my “peer” needs information to determine whether the company will cover a procedure I requested for one of my patients.

Health Insurance Companies 108

Health Insurance Companies Insurance 108

Fierce Healthcare

APRIL 26, 2024

The Federal Trade Commission (FTC) finalized a rule Friday that aims to tighten the reins on digital health apps sharing consumers' sensitive medical data with tech companies. | The FTC finalized a rule Friday that aims to tighten the reins on digital health apps sharing consumers' sensitive medical data with tech companies.

106

106

Fierce Pharma

APRIL 26, 2024

GSK pulls Pfizer and BioNTech into another vaccine patent lawsuit, this time surrounding the partners' mRNA-based COVID shots fkansteiner Fri, 04/26/2024 - 10:07

Vaccines 105

Vaccines 105

pharmaphorum

APRIL 26, 2024

Chemists at ETH Zurich have developed a new computer process that enables the generation of active pharmaceutical ingredients at speed, based on a protein’s three-dimensional surface.

105

105

The Checkup by Singlecare

APRIL 26, 2024

Sinus infections , also known as sinusitis, occur when a virus or bacteria causes inflammation and mucus buildup in your nasal passages. The swelling of the tissue lining your sinuses causes stuffy nose, facial pain, sneezing, runny nose, nasal congestion, sore throat, postnasal drip, and other symptoms that can feel similar to a common cold. They vary in length of illness and severity.

Hospitals 103

Hospitals Immunization 103

Pharmaceutical Commerce

APRIL 26, 2024

The latest news for pharma industry insiders.

102

102

Drug Topics

APRIL 26, 2024

Check out important updates from the FDA for the week of April 22.

FDA 98

FDA 98